Alta Capital Management Llc/ 13F: Adds $1.5M to CME Stake
Key Points
- Alta Capital Management's increase of 5,878 shares represents a 13.3% boost, raising its total holdings to 50,200 shares.
- The CME Group stock closed at $308.06 on October 26, 2026, while it recently traded around $305.71, slightly below the event close.
- The fund's position in CME now makes up 1.23% of its total reported value of about $1.07 billion.
Get CME Group text alerts
We text you when insiders, Congress, analysts or big funds move on $CME.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated CME Group Inc. alert may contain errors. Disclosures
On October 26, 2026, Alta Capital Management boosted its stake in CME Group Inc. (CME) by 5,878 shares, raising its total holdings to 50,200 shares valued at approximately $13.2 million. This information comes from the fund's latest Form 13F filing with the SEC.
CME
CME Group Inc.
What Changed in Alta Capital Management's CME Position
Alta Capital Management's increase of 5,878 shares represents a 13.3% boost in its position. The fund's total reported value in CME Group now stands at about $13,151,592.
Where CME Group Fits in Alta Capital Management's Portfolio
CME Group accounts for 1.23% of Alta Capital Management's total reported value of $1,065,066,094. The fund ranks 24th among its 215 holdings, indicating a notable position within its portfolio.
Other Institutional Activity in CME Group
On the same day, Miller Howard Investments increased its CME stake by 33,169 shares, bringing its total to 192,542 shares worth about $50.4 million. Meanwhile, Marathon Asset Management trimmed its holdings by 7,675 shares, ending with 87,498 shares. Sagespring Wealth Partners also reduced its stake by 5,482 shares, now holding 24,221 shares.
CME Group Inc. Stock Down 0.1%
CME Group shares closed at $308.06 on October 26, 2026. Recently, the stock has traded around $305.71, which is slightly below its event close. This movement is important as it reflects the market's sentiment following the fund's increased stake.
Recent Earnings
CME Group reported trailing twelve-month revenue of approximately $6.96 billion, with an impressive net margin of 63.5%. The next earnings report is expected on February 3, 2027.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
2 target cuts vs 0 raises.
-
EPS & revenue
EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.
-
Profit surprise
EBITDA missed by 6 percent. Operating income missed by 5 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
2 target cuts.
-
Earnings quality
Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.
Earnings Call Summary
CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.
Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.
Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.
Dividend
CME Group pays an annual dividend of $5.20 per share, with a payout ratio of 95.4%.
Insider Buying and Selling at CME Group Inc.
Recently, CEO Terrence A. Duffy sold 15,000 shares on September 10, 2026, valued at about $4.12 million. Director Elizabeth A. Cook also sold 500 shares on September 14, 2026, for approximately $140,055. In contrast, Director William R. Shepard bought 292 shares on September 25, 2026, at an average price of $268.76, totaling about $78,626.
Analysts Set New Price Targets
On October 22, 2026, several analysts maintained their ratings on CME Group. UBS kept a Neutral rating with a target of $310, while Morgan Stanley maintained an Overweight rating with a target of $359. Barclays, Wells Fargo, and Piper Sandler also reiterated their Overweight or Equal-Weight ratings with varying target increases.
About CME Group
CME Group Inc. operates contract markets for trading futures and options on futures worldwide. Its offerings include financial products based on interest rates, equity indexes, and commodities. The company's performance is closely watched due to its significant role in global financial services.
Bottom Line
Investors will be looking for CME Group's next earnings report on February 3, 2027, to gauge its performance moving forward. Alta Capital Management's filing shows a clear commitment to increasing its stake in the company, reflecting confidence in CME's future potential.
Related Filing Alerts
Source: Alta Capital Management Llc/'s 13F filing on $CME (Oct 26, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts